“…7,8 Other guidelines or consensus documents have been published by Mitchell et al 9 and Pauliekhoff et al 10 The change in visual function is assessed by visual acuity (VA) measurement at the baseline and all follow-up visits while the macular morphology is accurately assessed by optical coherence tomography (OCT; spectral domain (SD) or higher specification). OCT is a non-invasive imaging modality of the posterior pole that yields important information on the health of the neurosensory retina, retinal pigment epithelium-Bruch's membrane complex and choroidal vasculature and the modulation of these layers with anti-VEGF therapy.…”
“…7,8 Other guidelines or consensus documents have been published by Mitchell et al 9 and Pauliekhoff et al 10 The change in visual function is assessed by visual acuity (VA) measurement at the baseline and all follow-up visits while the macular morphology is accurately assessed by optical coherence tomography (OCT; spectral domain (SD) or higher specification). OCT is a non-invasive imaging modality of the posterior pole that yields important information on the health of the neurosensory retina, retinal pigment epithelium-Bruch's membrane complex and choroidal vasculature and the modulation of these layers with anti-VEGF therapy.…”
“…Es ergab sich eine signifikante Abwei Diskussion Von den deutschen Fachgesellschaf ten wurde bereits seit 2012 ein zeitna her Behandlungsbeginn mit AntiVEGF IVOMs bei allen Indikationen empfohlen [1]. Auch die britische Fachgesellschaft empfiehlt, die Behandlung innerhalb von14 Tagen zu beginnen: "Ideally new pati ents with AMD should not have to wait more than 1 week from referral to clinic and not more than 1 week from clinic to treatment if needed"[10]. Im Rahmen der OCEANStudie wurde aber gezeigt, dass die mittlere Zeitdauer von erster Visus messung bis zur ersten IVOM im deut…”
Every patient should be treated within 14 days, following recent recommendations of the ophthalmological societies. Liability issues have to be considered as the statistical evaluation of real life data showed unambiguous results.
“…10 Current guidelines for the management of nAMD state that conventional intravascular fluorescein and/or ICGA are mandatory for diagnosis as they are the basis for visualization of the entire neovascular lesion. [11][12][13] Follow-up may be effectively monitored by OCT alone.…”
mentioning
confidence: 99%
“…18,20 Despite the evident benefits of OCTA, 21,22 it has not found its way into primary nAMD diagnosis, and treatment guidelines and FA/ICGA are still considered the gold standard for a comprehensive evaluation of lesion location and morphology. [11][12][13] Current efforts to fully explore and understand the capabilities of OCTA and to set the basis for future diagnostic and therapeutic criteria in nAMD include comparisons of FA and OCTA, [23][24][25] as well as ICGA and OCTA [26][27][28] with variable conclusions.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.